FLNA — Filana Therapeutics, Inc.
$0.6355-2.84%
Last close: · regular session
After-hours $0.6500 +2.28% ·
Last 60 sessions
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for FLNA in the TickerWise workspace.
Filana Therapeutics, Inc. is a company dedicated to pioneering new pharmaceutical products and diagnostic technologies. A key area of its research is focused on creating potential treatments for Alzheimer's disease, including the investigational compounds PTI-125 and PTI-125Dx. Established by Remi Barbier in May 1998, the firm maintains its principal office in Austin, Texas.
Company profile
- Sector: Healthcare
- Industry: Biotechnology
- Country: US
- Exchange: NASDAQ
- Employees: 19
- Website: https://www.filanatx.com
Latest SEC filings for FLNA
Latest FLNA news
- Filana Therapeutics to Participate in the 2026 Maxim Growth Summit Read article
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.